Abstract
No public abstract is available from the verified source records.
Yeqing Zhou, Guihong Xuan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Contemporary management of the clinically N0 neck in oral squamous cell carcinoma
10.1016/j.oraloncology.2025.107839 · 2026
De-escalation strategies in the treatment of oral squamous cell carcinoma: a cross-sectional study in oral and maxillofacial surgery in Germany, Austria, and Switzerland
10.1016/j.jcms.2026.104478 · 2026
Less is more: exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
10.1016/j.canlet.2024.217095 · 2024
Impact of extranodal extension in metastatic cutaneous squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
10.1002/hed.28251 · 2025
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
10.1093/annonc/mdy218 · 2018
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma
10.1016/j.oraloncology.2026.107882 · 2026
Response-adapted surgery after neoadjuvant immunochemotherapy in oral squamous cell carcinoma
10.1016/j.oraloncology.2025.107769 · 2025
Insights into the use of DNA content in head and neck squamous cell carcinoma as a method for patient stratification and targeted therapy: revisiting old concepts and exploring new possibilities
10.1016/j.jormas.2025.102260 · 2025
De-escalating radiotherapy in pathologic complete response oral cancer after neoadjuvant immunochemotherapy: equal survival, better life, and a biomarker guide
10.3389/fonc.2026.1761516 · 2026
Incorporation of grade into stage in oral cavity squamous cell carcinoma: a novel staging schema
10.1016/j.oraloncology.2025.107847 · 2026
Role of immunotherapy in the management of oral squamous cell carcinoma: a systematic review
10.1016/j.jormas.2026.102722 · 2026
Breaking new ground in cervical metastatic carcinoma of unknown primary: neoadjuvant immunochemotherapy's pathologic regression and survival advantage
10.1245/s10434-025-18739-y · 2026
The efficacy of neoadjuvant chemotherapy as compared to upfront surgery for the management of oral squamous cell carcinoma: a systematic review and meta-analysis
10.1016/j.ijom.2023.03.007 · 2024
Adjuvant radiotherapy for patients with clinical T3–4 oral and oropharyngeal cancer who achieved major pathologic response after neoadjuvant immunochemotherapy and surgery: a propensity score-matched retrospective study
10.3389/fimmu.2025.1681587 · 2026
Comparison of alternative N-staging models in patients with oral cancer. Is nodal yield or burden the most critical parameter?
10.1016/j.jormas.2023.101594 · 2023
Pathologic response and survival after neoadjuvant immunotherapy for resectable mucosal HNSCC: a systematic review and meta-analysis
10.1001/jamaoto.2025.4573 · 2026
Metrics of pN-staging in oral squamous cell carcinoma: an analysis of 1,905 patients
10.1016/j.ejca.2021.03.019 · 2021
Prognostic implications of the 8th edition American joint committee on cancer (AJCC) staging system in oral cavity squamous cell carcinoma
10.1016/j.oraloncology.2018.08.013 · 2018
Pathologic treatment effect and survival in HPV-negative HNSCC following neoadjuvant nivolumab
10.1001/jamaoto.2025.1707 · 2025
Primary tumor staging for oral cancer and a proposed modification incorporating perineural invasion: an international multicenter study
2023
Oncological outcomes of pathological extranodal extension (pENE) in oral squamous cell carcinoma (OSCC): a proposal to refine the current staging
10.1016/j.oraloncology.2025.107281 · 2025
10.1016/j.critrevonc.2025.104742
10.1016/j.critrevonc.2025.104742 · 2025
Optimal adjuvant therapy of head and neck squamous cancer after primary surgical resection
10.1016/j.otc.2025.08.018 · 2026
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
10.1016/j.annonc.2021.03.006 · 2021
Reappraising the TNM staging system for oral cavity squamous cell carcinoma: an age-related prognosis analysis
10.1007/s00405-025-09385-x · 2025
Prognostic significance of extranodal extension in cervical lymph node metastases of head and neck squamous cell carcinoma: a systematic review and meta-analysis with bibliometric overview
10.1016/j.oraloncology.2026.107862 · 2026
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
10.1093/annonc/mdz019 · 2019
Improving accuracy in nodal staging of oral cancer: proposal of a new system
10.1016/j.suronc.2024.102033 · 2024
Percentage and size of residual viable tumor in lymph node: performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
10.1016/j.humpath.2024.05.009 · 2024
Global incidence, mortality, and risk factors of stroke in multi-modality head and neck cancer treatment: a systematic review and meta-analysis
10.1002/hed.28109 · 2025
Comprehensive analysis of prognostic value of lymph node staging classifications in patients with head and neck squamous cell carcinoma after cervical lymph node dissection
10.1016/j.ejso.2021.01.020 · 2021
Neoadjuvant chemoimmunotherapy brings superior quality of life of patients with locally advanced oral or oropharyngeal cancer: a propensity score-matched analysis
10.1016/j.oraloncology.2025.107218 · 2025
The prognostic value of preoperative fibrinogen and its combination with platelet-to-lymphocyte ratio in oral squamous cell carcinoma
10.1016/j.joms.2026.02.013 · 2026
Neoadjuvant immunochemotherapy does not increase major surgical complications in oral cavity cancer
10.1016/j.jcms.2026.104535 · 2026
Effect of neoadjuvant chemotherapy on the clinical outcomes and immune microenvironment in oral squamous cell carcinoma
10.1016/j.jcms.2025.07.019 · 2025
No additional external references are available.